- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03350555
Clinical Trials to Validate the Use of Additioned Endoscopy in Endoscopic Retrograde Cholangiopancreatography
November 20, 2017 updated by: Xiangyu Kong, Changhai Hospital
Validation of Clinical Use of Additioned Endoscopy in Endoscopic Retrograde Cholangiopancreatography
Validation of clinical use of additioned endoscopy in Endoscopic Retrograde Cholangiopancreatography(ERCP) treatment.
Study Overview
Detailed Description
Investigators recently developed a device named additioned Endoscopy.
The purpose of current clinical trial is to evaluate the use of additioned endoscopy in ERCP treatment, specifically in shortening the duration of ERCP operation and lowering incidence of complications.
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200433
- Recruiting
- Changhai Hospital, Second Military Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- People who are indicated to ERCP treatment.
Exclusion Criteria:
- People who are not suitable for ERCP treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ERCP with additioned endoscopy
This arm will include participants undergoing ERCP with assistance of additioned endoscopy.
|
To evaluate the use of additioned endoscopy in ERCP treatment.
|
No Intervention: ERCP without additioned endoscopy
This arm will include participants undergoing ERCP without assistance of additioned endoscopy as negative controls.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of ERCP treatment
Time Frame: Duration of operation in each patient, ie. from beginning to the end of ERCP operation in each patient
|
To test if additioned endoscopy will have impact on duration of ERCP treatment
|
Duration of operation in each patient, ie. from beginning to the end of ERCP operation in each patient
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
complications of ERCP treatment
Time Frame: up to 1 month after ERCP completion
|
To test if additioned endoscopy will have impact on incidence of ERCP complications, including perforation, bleeding, post-ERCP pancreatitis.
|
up to 1 month after ERCP completion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Zhaoshen Li, MD, Changhai hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 1, 2017
Primary Completion (Anticipated)
December 1, 2019
Study Completion (Anticipated)
December 1, 2019
Study Registration Dates
First Submitted
November 10, 2017
First Submitted That Met QC Criteria
November 20, 2017
First Posted (Actual)
November 22, 2017
Study Record Updates
Last Update Posted (Actual)
November 22, 2017
Last Update Submitted That Met QC Criteria
November 20, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- Additioned Endocopy in ERCP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ERCP
-
Istituto Clinico HumanitasRecruiting
-
University of CalgaryMcGill University; University of Ottawa; Queen's University; Halton Health (Oakville) and other collaboratorsCompleted
-
The University of Texas Health Science Center,...Wake Forest University Health Sciences; Instituto Ecuatoriano de Enfermedades...Unknown
-
Air Force Military Medical University, ChinaDepartment of Endoscopy, Eastern Hepatobiliary Hospital, Second Military... and other collaboratorsRecruiting
-
Menoufia UniversityCompletedERCP, Difficult CBD CannulationEgypt
-
Postgraduate Institute of Medical Education and...AMRI Hospital, Salt Lake, Kolkata, IndiaCompleted
-
Assiut UniversityCompleted
-
National Cancer Institute, EgyptCompletedSedation in ERCPEgypt
-
Hospital Clinic of BarcelonaUnknownPatient Population Submitted to ERCPSpain
Clinical Trials on Additioned Endoscopy
-
Chinese University of Hong KongCompletedGastrointestinal Bleeding | Bleeding Peptic Ulcer | Active BleedingChina
-
Weill Medical College of Cornell UniversityUnknownInterventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal DisordersColorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Cholangiocarcinoma | Bile Duct Cancer | Cholangitis | Barrett's Esophagus | Gallstones | Choledocholithiasis | Bile Leak | Obstructive Jaundice | Duodenal Cancer | Pancreatic Pseudocysts | Ampullary Cancer | Biliary Strictures | Recurrent Pancreatitis | Bile Duct... and other conditionsUnited States
-
Unidade Local De Saúde Do Norte AlentejanoNOVA Medical SchoolRecruiting
-
Jagiellonian UniversityCompleted
-
University Medical Center GroningenMaastricht University Medical Center; Erasmus Medical Center; Medtronic - MITG; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and other collaboratorsCompletedLynch Syndrome | Small Bowel NeoplasiaNetherlands
-
Hvidovre University HospitalTerminatedUpper Gastrointestinal Disease,UlcersDenmark
-
Technical University of MunichRotkreuzklinikum München gGmbH; Klinikum Freising; Klinikum Landshut-Achdorf; Städtisches... and other collaboratorsCompletedEndoscopic Diagnosis in EsophagusGermany
-
Dallas VA Medical CenterCompleted
-
Johns Hopkins UniversityEthicon, Inc.WithdrawnEsophageal and Gastric VaricesUnited States
-
University Hospital, MontpellierTerminatedthe Management of Weight Regain After Gastric Bypass by Endoscopic SuturingFrance